TP53 and hepatocellular carcinoma: Further, in a combinatorial therapy for TP53 mutant hepatocellular carcinoma, Wang et al. discovered that the CDC7 inhibitor XL413 inhibited many gene characteristics linked to DNA repair in TP53 mutant cells [129].